Paragon 28, Inc. 7GQ.F Stock
Paragon 28, Inc. Price Chart
Paragon 28, Inc. 7GQ.F Financial and Trading Overview
Paragon 28, Inc. stock price | 9.65 EUR |
Previous Close | 16.8 EUR |
Open | 16.6 EUR |
Bid | 16.6 EUR x N/A |
Ask | 17.1 EUR x N/A |
Day's Range | 16.6 - 16.6 EUR |
52 Week Range | 14.5 - 20 EUR |
Volume | 10 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.4B EUR |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.54 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
7GQ.F Valuation Measures
Enterprise Value | 1.33B EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 7.274446 |
Price/Book (mrq) | 6.658644 |
Enterprise Value/Revenue | 6.934 |
Enterprise Value/EBITDA | -67.345 |
Trading Information
Paragon 28, Inc. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 10.59% |
S&P500 52-Week Change | 20.43% |
52 Week High | 20 EUR |
52 Week Low | 14.5 EUR |
50-Day Moving Average | 16.1 EUR |
200-Day Moving Average | 17.28 EUR |
7GQ.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 82.32M |
Float | 34.18M |
Short Ratio | N/A |
% Held by Insiders | 42.15% |
% Held by Institutions | 38.27% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -34.96% |
Operating Margin (ttm) | -17.48% |
Gross Margin | 81.99% |
EBITDA Margin | -10.29% |
Management Effectiveness
Return on Assets (ttm) | -7.21% |
Return on Equity (ttm) | -34.46% |
Income Statement
Revenue (ttm) | 192.05M EUR |
Revenue Per Share (ttm) | 2.47 EUR |
Quarterly Revenue Growth (yoy) | 25.80% |
Gross Profit (ttm) | 148.93M EUR |
EBITDA | -19775000 EUR |
Net Income Avi to Common (ttm) | -67142000 EUR |
Diluted EPS (ttm) | -0.8 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 85.88M EUR |
Total Cash Per Share (mrq) | 1.04 EUR |
Total Debt (mrq) | 42.89M EUR |
Total Debt/Equity (mrq) | 20.91 EUR |
Current Ratio (mrq) | 3.096 |
Book Value Per Share (mrq) | 2.493 |
Cash Flow Statement
Operating Cash Flow (ttm) | -53738000 EUR |
Levered Free Cash Flow (ttm) | -35935000 EUR |
Profile of Paragon 28, Inc.
Country | Germany |
State | CO |
City | Englewood |
Address | 14445 Grasslands Drive |
ZIP | 80112 |
Phone | 720 912 1332 |
Website | https://www.paragon28.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 463 |
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Q&A For Paragon 28, Inc. Stock
What is a current 7GQ.F stock price?
Paragon 28, Inc. 7GQ.F stock price today per share is 9.65 EUR.
How to purchase Paragon 28, Inc. stock?
You can buy 7GQ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Paragon 28, Inc.?
The stock symbol or ticker of Paragon 28, Inc. is 7GQ.F.
Which industry does the Paragon 28, Inc. company belong to?
The Paragon 28, Inc. industry is Medical Devices.
How many shares does Paragon 28, Inc. have in circulation?
The max supply of Paragon 28, Inc. shares is 82.91M.
What is Paragon 28, Inc. Price to Earnings Ratio (PE Ratio)?
Paragon 28, Inc. PE Ratio is now.
What was Paragon 28, Inc. earnings per share over the trailing 12 months (TTM)?
Paragon 28, Inc. EPS is -0.54 EUR over the trailing 12 months.
Which sector does the Paragon 28, Inc. company belong to?
The Paragon 28, Inc. sector is Healthcare.